Cancer Screening? There’s an ARK ETF for That
February 09, 2021 at 13:23 PM EST
Cancer therapies and treatments are among the biggest markets in the broader biotechnology sector, and genomics is one of the preferred avenues for that exposure. Enter the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Cancer screening is among the many rapidly evolving genomics frontiers...